Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 53,471 | 211,669 | 162,261 | 113,686 | 40,184 |
| Depreciation Amortization | 3,301 | 14,653 | 11,311 | 7,807 | 3,966 |
| Income taxes - deferred | -276 | 11,338 | 6,523 | 4,543 | 1,961 |
| Accounts receivable | 216 | 234 | 600 | 600 | 600 |
| Accounts payable and accrued liabilities | -570 | 546 | 285 | -373 | -57 |
| Other Working Capital | -3,794 | -25,807 | -21,734 | -3,672 | -28,503 |
| Other Operating Activity | 507 | -127 | -624 | 202 | -255 |
| Operating Cash Flow | $52,855 | $212,506 | $158,622 | $122,793 | $17,896 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -51 | -18 | -19 | -8 |
| Purchase Of Investment | N/A | -29,898 | -25,992 | -5,993 | -5,993 |
| Sale Of Investment | 12,405 | 50,831 | 36,799 | 20,000 | 14,000 |
| Other Investing Activity | 6,700 | -92,590 | -48,264 | -7,425 | -7,425 |
| Investing Cash Flow | $19,105 | $-71,708 | $-37,475 | $6,563 | $574 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -93,370 | -93,370 | -70,632 | -23,839 |
| Dividend Paid | -20,980 | -83,942 | -62,886 | -41,924 | -20,962 |
| Other Financing Activity | 0 | -818 | -845 | -838 | -845 |
| Financing Cash Flow | $-20,980 | $-178,130 | $-157,101 | $-113,394 | $-45,646 |
| Beginning Cash Position | 131,212 | 168,544 | 168,544 | 168,544 | 168,544 |
| End Cash Position | 182,192 | 131,212 | 132,590 | 184,506 | 141,368 |
| Net Cash Flow | $50,980 | $-37,332 | $-35,954 | $15,962 | $-27,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | 52,855 | 212,506 | 158,622 | 122,793 | 17,896 |
| Capital Expenditure | N/A | -51 | -18 | -19 | -8 |
| Free Cash Flow | 52,855 | 212,455 | 158,604 | 122,774 | 17,888 |